Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 7. Promoter methylation level of XRCC1 in pan-cancer. (A) in BRCA, (B) in COAD, (C) in ESCA, (D) in KIRC, (E) in KIRP, (F) in LUSC, (G) in PAAD, (H) in READ, (I) in SARC, (J) in THCA.